Radioiodine therapy in patients with Graves′ disease and the effects of prior carbimazole therapy
The use of radioiodine as the first line of treatment in Graves′ disease is restricted in India because of its limited availability and an unrealistic risk perception associated with it. Additionally, the effectiveness of radioiodine ablation in Graves′ disease is influenced by many factors. Prior m...
Main Authors: | Arun Karyampudi, Abdoul Hamide, Dhanapathi Halanaik, Jaya Prakash Sahoo, Sadishkumar Kamalanathan |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2014-01-01
|
Series: | Indian Journal of Endocrinology and Metabolism |
Subjects: | |
Online Access: | http://www.ijem.in/article.asp?issn=2230-8210;year=2014;volume=18;issue=5;spage=688;epage=693;aulast=Karyampudi |
Similar Items
-
Effects of Radioiodine Therapy on the Natural History of Graves' Ophtalmopathy
Published: (2007-09-01) -
Long-term carbimazole pretreatment reduces the efficacy of radioiodine therapy
by: C Shivaprasad, et al.
Published: (2015-01-01) -
Radioiodine treatment for graves’ disease: a 10-year Australian cohort study
by: Erin Fanning, et al.
Published: (2018-12-01) -
Concomitant lithium increases radioiodine uptake and absorbed doses per administered activity in graves’ disease: comparison of conventional versus lithium-augmented radioiodine therapy
by: Fadi Khreish, et al.
Published: (2024-04-01) -
Long-term outcome and prognostic factors of single-dose Radioiodine Therapy in patients with Graves' disease
by: Yi-Ting Yang, et al.
Published: (2020-05-01)